Morgan Stanley analyst Megan Alexander Clapp raised the firm’s price target on Vital Farms (VITL) to $48 from $41 and keeps an Overweight rating on the shares. A Q2 beat and guidance raise “underscore accelerating growth momentum,” the analyst tells investors in a post-earnings note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VITL:
- Vital Farms price target raised to $50 from $44 at BMO Capital
- Vital Farms: Strong Market Performance and Strategic Growth Drive Buy Rating
- Vital Farms Reports Strong Q2 2025 Growth
- Vital Farms’ Strong Q2 Performance and Raised 2025 Guidance Justify Buy Rating
- Vital Farms reports Q2 EPS 36c, consensus 27c